par Partridge, Ann A.H.;Gelber, Shari;Piccart-Gebhart, Martine
;Focant, Florine;Scullion, Matthew;Holmes, Eileen;Winer, Eric E.P.;Gelber, Richard
Référence Journal of clinical oncology, 31, 21, page (2692-2698)
Publication Publié, 2013-07
;Focant, Florine;Scullion, Matthew;Holmes, Eileen;Winer, Eric E.P.;Gelber, RichardRéférence Journal of clinical oncology, 31, 21, page (2692-2698)
Publication Publié, 2013-07
Article révisé par les pairs
| Titre: |
|
| Auteur: | Partridge, Ann A.H.; Gelber, Shari; Piccart-Gebhart, Martine; Focant, Florine; Scullion, Matthew; Holmes, Eileen; Winer, Eric E.P.; Gelber, Richard |
| Informations sur la publication: | Journal of clinical oncology, 31, 21, page (2692-2698) |
| Statut de publication: | Publié, 2013-07 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adult |
| Age Factors | |
| Antibodies, Monoclonal, Humanized -- therapeutic use | |
| Antineoplastic Agents -- therapeutic use | |
| Breast Neoplasms -- drug therapy -- enzymology -- pathology | |
| Chemotherapy, Adjuvant | |
| Female | |
| Humans | |
| Proportional Hazards Models | |
| Receptor, ErbB-2 -- metabolism | |
| Retrospective Studies | |
| Treatment Outcome | |
| Young Adult | |
| Note générale: | SCOPUS: ar.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0732-183X |
| info:doi/10.1200/JCO.2012.44.1956 | |
| info:pii/JCO.2012.44.1956 | |
| info:scp/84886615995 | |
| info:pmid/23752109 |



